Synthesis of medicinally important N-trimethylene dipiperidine sulfonamides and carboxamides containing a substituted benzophenone moiety - An antibacterial agents

Letters in Drug Design and Discovery

Volumn 5, Issue 4, 2008, Pages 250-260

  Vinaya, Mallappanahally Kambappa ^a   Naika, Hanuma Raja ^b   Kumar, Channapille Koppal Siddegowda Ananda ^a   Prasad, Salekoppal Boregowda Benaka ^a   Chandrappa, Siddappa ^a   Ranganatha, Somasagara Ramanna ^a   Krishna, Venkatarangaiah ^b   Rangappa, Kanchugarakoppal Subbegowda ^a  

^a UNIVERSITY OF MYSORE   (India)

^b KUVEMPU UNIVERSITY   (India)

Author keywords

(4 hydroxyphenyl)(2,4 dimethoxyphenyl)methanone; 1,3 Dimethoxy benzene; Acid chlorides; Antibacterial activity; N Methyl morpholine; Sulfonyl chlorides

Indexed keywords

1 [4 [3 (1 BENZENESULFONYLPIPERIDIN 4 YL)PROPYL]PIPERIDIN 1 YL] 2 [4 (2,4 DIMETHOXYBENZOYL)PHENOXY]ETHANONE; 1 [4 [3 (1 BENZOYLPIPERIDIN 4 YL)PROPYL]PIPERIDIN 1 YL] 2 [4 (2,4 DIMETHOXYBENZOYL)PHENOXY]ETHANONE; 1 [4 [3 [1 (2,4 DICHLOROBENZOYL)PIPERIDIN 4 YL]PROPYL]PIPERIDIN 1 YL] 2 [4 (2,4 DIMETHOXYBENZOYL)PHENOXY]ETHANONE; 1 [4 [3 [1 (2,5 DICHLOROBENZENESULFONYL)PIPERIDIN 4 YL]PROPYL]PIPERIDIN 1 YL] 2 [4 (2,4 DIMETHOXYBENZOYL)PHENOXY]ETHANONE; 1 [4 [3 [1 (4 CHLOROBENZENESULFONYL)PIPERIDIN 4 YL]PROPYL]PIPERIDIN 1 YL] 2 [4 (2,4 DIMETHOXYBENZOYL)PHENOXY]ETHANONE; 1 [4 [3 [1 (4 TERT BUTYL BENZOYL)PIPERIDIN 4 YL]PROPYL]PIPERIDIN 1 YL] 2 [4 (2,4 DIMETHOXYBENZOYL)PHENOXY]ETHANONE; 1 [4 [3 [1 (4 TERT BUTYLBENZENESULFONYL)PIPERIDIN 4 YL]PROPYL]PIPERIDIN 1 YL] 2 [4 (2,4 DIMETHOXYBENZOYL)PHENOXY]ETHANONE; 2 [4 (2,4 DIMETHOXYBENZOYL)PHENOXY] 1 [4 [3 [1 (2 FLUOROBENZOYL)PIPERIDIN 4 YL]PROPYL]PIPERIDIN 1 YL]ETHANONE; 2 [4 (2,4 DIMETHOXYBENZOYL)PHENOXY] 1 [4 [3 [1 (3 METHOXYBENZOYL)PIPERIDIN 4 YL]PROPYL]PIPERIDIN 1 YL]ETHANONE; 2 [4 (2,4 DIMETHOXYBENZOYL)PHENOXY] 1 [4 [3 [1 (3,5 DINITROBENZOYL)PIPERIDIN 4 YL]PROPYL]PIPERIDIN 1 YL]ETHANONE; AMIDE; BENZOPHENONE; SULFONAMIDE;

AGAR DIFFUSION; ANTIBACTERIAL ACTIVITY; ARTICLE; BACILLUS SUBTILIS; BROTH DILUTION; DRUG EFFICACY; DRUG STRUCTURE; DRUG SYNTHESIS; ESCHERICHIA COLI; IN VITRO STUDY; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PYOGENES; STRUCTURE ACTIVITY RELATION;

EID: 45249123028     PISSN: 15701808     EISSN: None     Source Type: Journal    
DOI: 10.2174/157018008784619951     Document Type: Article

References (40)

1. Colapret, J.A.; Diamantidis, G.; Spencer, H.K. J. Med. Chem., 1989, 32, 968.
2. Klockgether, T.; Wullner, J.P.; Steinbach, Petersen, V.; Turski, L.; Loschmann, P.A. Eur. J. Pharmacol., 1996, 301, 67.
3. Stephen, R.F.; Frank, B.; Peter, B.; Susan, K.F.; Cheng, C.; O'Connor, R.D.; Daniel, S.; Matthew, T.; Monique, B.; van Niel, P.S.; Kerry, C.; Rose, M.; Sara, S.; Graham, B.; Gina, P.C.; Linda, J.B.; Jose, L.C.; Peter, H.H.; Angus, M.M. J. Med. Chem., 2002, 45(2), 492.
4. Christopher, A.W.; Scott, C.B.; Keith, G.R.; Silvia, D.; Kevin, T.C.; Sandra, L.G.; Martin, S.S.; Lorraine, M.; William, A.S.; Daria, H.; Michael, M.; Joseph, K.; Renee, D.; Karen, H.; Janet, L.; Anthony, C.; Gwen, C.; Emilio, A.E. Bioorg. Med. Chem. Lett., 2001, 11, 3137.
5. Lihu, Y.; Greg, M.A.; Arthur, P.; Kwan, L.; Tom, J.; Kang, C.; Klaus, D.S.; William, F.; Wanda, W.S.C.; Shuet-Hing, L.C.; Roy, G.S. J. Med. Chem., 1998, 41 (14), 2439.
6. Seza, A.; Elif, L.; Atilla, O. J. Enz. Inhi. Med. Chem., 2006, 21(2), 211.
7. Anna, C.; Zofia, D.S.; Bożenna, R.; Maja, K.; Edyta, W. Cell. Mol. Biol. Lett., 2002, 7, 266.
8. Amat, M.; Hidalgo, J.; Bosch, J. Tetrahedron Asymmetry, 1996, 7, 1845.
9. Jean-Marie, C.; Isabelle, P.; Wolfgang, S.; Yveline, M.R.; Camille, G.W. J. Med. Chem., 2001, 44, 2707.
10. Maniyan, P.; Bernard, S.; Yuxiang, D.; Jacques, C.; Hugues, M.; Susan, A.C.; Darren, J.C.; William, N.C.; Josefina, S.T.; Christian, S.; Sergio, W.; Reto, B.; Jonathan, L.V. Bioorg. Med. Chem. Lett., 2006, 16, 5542.
11. Reddy, P.A.; Woodward, K.E.; McIlheran, S.M.; Hsiang, B.C.; Latifi, T.N.; Hill, M.W.; Rothman, S.M.; Ferrendelli, J.A.; Covey, D.F. J. Med. Chem., 1997, 40, 44.
12. Matthew, W.H.; Reddy, P.A.; Douglas, F.C.; Steven, M.R. J. Pharmacol. Exp. Ther., 1998, 285, 1303.
13. Shen, S.Y.; Tsai, H.J.; Chiang, H.C. Anticancer Res., 1999, 19, 1131.
14. Burns, D.T.; Tungkananuruk, N.; Thuwasin, S. Anal. Chim. Acta, 2000, 41, 419.
15. Kadry, A.M.; Okereke, C.S.; Abdel-Rahman, M.S.; Friedman, M.A.; Davis, R.A. J. Appl. Toxicol., 1995, 15, 97.
16. Okereke, C.S.; Barat, S.A.; Abdel-Rahman, M.S. Toxicol. Lett., 1995, 80, 61.
17. Collins, P.; Ferguson, J. Br. J. Dermatol., 1994, 131, 124.
18. De Souza, A.O.; Alderete, J.B.; Schimidt, F.; Sato, D.N.; Duran, N. Drug Research., 1999, 49, 1025.
19. Karash, N.; Terzioglu, N.; Gursoy, A. Arzneim. Forsch Drug Res., 1998, 48, 758.
20. Khafagy, M.M.; Abd.El-Waheb, A.H.F.; Eid, F.A.; El-Agrody, A.M. Farmaco., 2002, 57, 715.
21. Wunz, T.P.; Dorr, R.T.; Alberts, D.S.; Tunget, C.L.; Einspahr, J.; Milton, S.; Remers, W.A. J. Med. Chem., 1987, 30, 1313.
22. Wyatt, P.G.; Bethell, R.C.; Cammack, N.; Charon, D.; Dodic, N.; Dumaitre, B.; Evans, D.N.; Green, D.V.; Hopewell, P.L.; Humber, D.C. J. Med. Chem., 1995, 38, 1657.
23. Kirk, R.G.; John, W.B.; Murray, H.G.M.; Richard, W.F.; Tawnya, C.M.; John, H.C.; James, B.M.; Gordon, M.C.; Michael, R.B. Tetrahedron, 1992, 48, 10093.
24. Hsieh, H.P.; Liou, J.P.; Lin, Y.T.; Mahindroo, N.; Chang, J.Y.; Yang, Y.N.; Chern, S.S.; Tan, U.K.; Chang, C.W.; Chen, T.W.; Lin, C.H.; Chang, Y.Y.; Wang, C.C.; Bioorg. Med. Chem. Lett., 2003, 13, 101.
25. Finney, N.; Ghosh, S.; Hirst, J.; Norman, P.; Rotella, D.P. Curr. Opin. Drug Discov. Dev., 1999, 2, 175.
26. Padmakar, V.K.; Sharma, V.; Karmarkar, S.; Claudiu, T.S. Bioorg. Med. Chem. Lett., 2005, 15 (4), 923.
27. Singh, S.K.; Reddy, P.G.; Rao, K.S.; Lohray, B.B.; Misra, P.; Rajjak, S.A.; Rao, Y.K.; Venkateswarlu, A. Bioorg. Med. Chem. Lett., 2004, 14 (2), 499.
28. Akira, K.; Masao, Y.; Masuo, M. Weed Biol. Manag., 2002, 2, 213.
29. Andrea, S.; Fabrizio, B.; Marc, A.I.; Calaudin, T.S. J. Med. Chem., 2000, 43(2), 292.
30. Andrea, S.; Calaudin, T.S. Eur. J. Med. Chem., 2000, 35, 299.
31. Medina, J.C.; Shan, B.; Beckmann, H.; Farrell, R.P.; Clark, D.L.; Learned, R.M.; Roche, D.; Li, A.; Baichwal, V.; Case, C.; Baeuerle, P.A.; Rosen, T.; Jaen, J.C. Bioorg. Med. Chem. Lett., 1998, 8, 2653.
32. Kirk, K.L.; Filler, R. In Biomedical frontiers of Fluorine Chemistry, Symposiumseries; American Chemical Society: Washington, DC, 1996, 639, 1.
33. Gelders, Y.G.; Heylen, S.L.E.; Vander Bussche, G.; Reyntjens, A.J.M.; Janssen, P.A.J. Pharmacopsychiatry, 1990, 23, 206.
34. Dollery, C. Therapeutic drugs, Churchill livingstone, Edinburgh, UK, 1999.
35. Priya, B.S.; Basappa, Nanjunda swamy, S.; Rangappa, K.S. Bioorg. Med. Chem., 2005, 13, 2623.
36. Sadashiva, M.P.; Mallesha, H.; Murthy, K.K.; Rangappa, K.S. Bioorg. Med. Chem. Lett., 2005, 15, 1811.
37. Nanjunda swamy, S.; Basappa, Sarala, G.; Priya, B.S.; Gaonkar, S.L.; Prasad, J.S.; Rangappa, K.S. Bioorg. Med. Chem. Lett., 2006, 16, 999.
38. Narendra Sharath Chandra, J.N.; Sadashiva, C.T.; Kavitha, C.V.; Rangappa, K.S. Bioorg. Med. Chem., 2006, 14, 6621.
39. Ananda Kumar, C.S.; Vinaya, K.; Narendra Sharath Chandra, J.; Thimmegowda, N.R.; Benaka Prasad, S.B.; Sadashiva, C.T.; Rangappa, K.S. J. Enz. Inhi. Med. Chem., 2008, 14, 1.
40. Mukherjee, P.K.; Balasubramanian, R.; Saha, K.; Saha, B.P.; Pal, M. Indian Drugs, 1995, 32, 274.